GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (BOM:544172) » Definitions » Common Stock

Indegene (BOM:544172) Common Stock : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Indegene Common Stock?

Indegene's quarterly common stock increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹478 Mil) but then declined from Sep. 2024 (₹478 Mil) to Dec. 2024 (₹0 Mil).

Indegene's annual common stock increased from Mar. 2022 (₹4 Mil) to Mar. 2023 (₹443 Mil) and increased from Mar. 2023 (₹443 Mil) to Mar. 2024 (₹444 Mil).


Indegene Common Stock Historical Data

The historical data trend for Indegene's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Common Stock Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Common Stock
3.13 3.51 442.95 444.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 443.51 444.00 - 478.00 -

Indegene Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Indegene Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines